Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the fourth quarter of 2024, aided by a 7% increase in sales.
Fourth-quarter worldwide sales increased 7% year-over-year to $15.6 billion, with Pharmaceutical and Animal Health revenues growing 7% and 9% respectively.
The company reported a net profit of $3.74 billion or $1.48 per share for the December quarter, compared to a loss of $1.23 billion or $0.48 per share in the prior-year period. On an adjusted basis, earnings climbed to $1.72 per share in Q4 from $0.03 per share in the fourth quarter of 2023.
“Our business remains well-positioned thanks to the dedication of our talented global team, and I am more confident than ever in our long-term growth potential,” said Merck’s CEO Robert Davis.
Prior Performance
The post MRK Earnings: Merck Q4 2024 adj. profit jumps on strong sales growth first appeared on AlphaStreet.
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the fourth quarter of 2024, aided by a 7% increase in sales. Fourth-quarter worldwide
The post MRK Earnings: Merck Q4 2024 adj. profit jumps on strong sales growth first appeared on AlphaStreet.
Categories AlphaGraphs, Earnings, Health Care
MRK Earnings: Merck Q4 2024 adj. profit jumps on strong sales growth
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the fourth quarter of 2024, aided by a 7% increase in sales.
Fourth-quarter worldwide sales increased 7% year-over-year to $15.6 billion, with Pharmaceutical and Animal Health revenues growing 7% and 9% respectively.
The company reported a net profit of $3.74 billion or $1.48 per share for the December quarter, compared to a loss of $1.23 billion or $0.48 per share in the prior-year period. On an adjusted basis, earnings climbed to $1.72 per share in Q4 from $0.03 per share in the fourth quarter of 2023.
“Our business remains well-positioned thanks to the dedication of our talented global team, and I am more confident than ever in our long-term growth potential,” said Merck’s CEO Robert Davis.
Prior Performance
Listen to the conference calls as they happen. Don’t miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Uber Technologies (UBER) Q4 2024 Earnings: Key financials and quarterly highlights
Uber Technologies, Inc. (NYSE: UBER) reported its fourth quarter 2024 earnings results today. Revenue grew 20% year-over-year to $12 billion, or 21% on a constant currency basis. Net income attributable
Earnings: Highlights of AMD’s Q4 2024 report
Chipmaker Advanced Micro Devices, Inc. (NASDAQ: AMD) on Tuesday announced financial results for the fourth quarter of 2024. Fourth-quarter earnings, on an adjusted basis, were $1.09 per share, compared to
GOOG Earnings: Alphabet’s Q4 2024 profit beats estimates; revenue up 12%
Alphabet Inc. (NASDAQ: GOOG, GOOGL), the parent of Internet search giant Google, Tuesday reported higher revenue and earnings for the fourth quarter of 2024. Earnings exceeded Wall Street’s estimates. Alphabet’s
Tags